Evaluation of USB005 in a Phase 1 Normal, Healthy Volunteer Ocular Safety and PK Study
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 31 Jan 2019
At a glance
- Drugs Aclerastide (Primary)
- Indications Wounds
- Focus Adverse reactions
- Sponsors US Biotest Inc
- 22 Jan 2019 Planned End Date changed from 1 Oct 2018 to 1 Feb 2019.
- 22 Jan 2019 Status changed from recruiting to active, no longer recruiting.
- 08 Aug 2018 New trial record